Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101

25th February 2026 Uncategorised 0

More than 200 participants enrolled as company targets topline data by end of 2026

More: Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
Source: News